The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Recruiting
Observational Study
Cancer-associated Thrombosis
Venous Thromboembolism
Gynecologic Cancer
Ovarian Cancer
Cervix Cancer
Endometrial Cancer
Vaginal Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 1,800 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female sex;
* Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm);
* Planned new line of systemic antineoplastic treatment;
* Age of 18 years or older;
* Accordance of Informed Consent.
Exclusion Criteria:
* Pregnant or breastfeedi…
Contacts